Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Value of early evaluation of treatment response using 18F-FDG PET/CT parameters and the Epstein-Barr virus DNA load for prediction of outcome in patients with primary nasopharyngeal carcinoma

Published:2018-09-27 Issue:3 Volume:46 Page:650-660
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Chen Yu-Hung,Chang Kai-Ping,Chu Sung-Chao,Yen Tzu-Chen,Wang Ling-Yi,Chang Joseph Tung-Chieh,Hsu Cheng-Lung,Ng Shu-Hang,Liu Shu-Hsin,Chan Sheng-Chieh

Funder

Ministry of Science and Technology, Taiwan

Chang Gung Memorial Hospital

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-4172-3/fulltext.html

Reference63 articles.

1. Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006;1:23.

2. Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387:1012–24.

3. Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer. 2011;30:114–9.

4. Wee CW, Keam B, Heo DS, Sung MW, Won TB, Wu HG. Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy. Radiat Oncol J. 2015;33:98–108.

5. Wei WI, Sham JST. Nasopharyngeal carcinoma. Lancet. 2005;365:2041–54.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current state, challenges, and future perspective of adaptive radiotherapy: A narrative review of nasopharyngeal carcinoma;Oral Oncology;2024-11

2. The prognostic value of pretreatment 18F-FDG PET-CT parameters with peripheral blood markers in patients with de novo metastatic nasopharyngeal carcinoma;Oral Oncology;2024-09

3. Global, regional, and national survey on burden and quality of care index (QCI) of nasopharyngeal cancer: A systematic analysis of the Global Burden of disease study 1990–2019;Oral Oncology Reports;2024-03

4. Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-19

5. Progress in the comprehensive treatment of nasopharyngeal carcinoma: a review for risk-stratified management strategies;Holistic Integrative Oncology;2023-07-03